Honest Joy Holdings

Honest Joy Holdings Limited is an investment holding company that serves as the controlling shareholder of Hansoh Pharmaceutical Group, one of China's leading research-driven pharmaceutical companies. Through its operating subsidiaries, the company focuses on the discovery, development, and commercialization of innovative drugs in high-growth therapeutic areas including oncology, central nervous system disorders, anti-infectives, and metabolic diseases. Its commercial portfolio features several internally developed blockbuster treatments such as almonertinib for lung cancer and flumatinib for leukemia. The company maintains a robust pipeline of over 30 innovative drug candidates, with a significant focus on next-generation modalities like antibody-drug conjugates. Honest Joy Holdings is the primary investment vehicle for Zhong Huijuan, the founder and chairwoman of Hansoh Pharma.